In a market obsessed with flashy biotech IPOs, Curia operates in the shadows of the industry—manufacturing the molecules that save lives. This isn't a startup; it's a 30-year-old powerhouse with $1.03B in revenue and 3,205 employees building the infrastructure of modern medicine.

"They're not selling software—they're selling the ability to mass-produce complex molecules at scale. That's moat."

Their tech stack reveals a pragmatic approach: jQuery, Bootstrap, and Tailwind CSS for a functional, no-nonsense web presence. This isn't a company wasting resources on flashy frontend experiments. Every dollar goes toward manufacturing capacity and R&D capabilities that pharmaceutical giants rely on.

• Full-service CDMO: research, development, and manufacturing under one roof
• 30+ years of industry experience and regulatory track record
• Massive workforce (3,205 employees) indicates industrial-scale operations
• Revenue exceeding $1B signals enterprise-level partnerships